(Q38434672)

3 September 2017

title

Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis (English)

1 reference

3 September 2017

2

Maurizio Montella

1 reference

3 September 2017

Francesco Izzo

1

1 reference

3 September 2017

Antonio Pio Orlando

3

1 reference

3 September 2017

Guglielmo Nasti

4

1 reference

3 September 2017

Gerardo Beneduce

5

1 reference

3 September 2017

Giuseppe Castello

6

1 reference

3 September 2017

Francesco Cremona

7

1 reference

3 September 2017

C Mark Ensor

8

1 reference

3 September 2017

Frederick W Holtzberg

9

1 reference

3 September 2017

John S Bomalaski

10

1 reference

3 September 2017

Mike A Clark

11

1 reference

3 September 2017

Steven A Curley

12

1 reference

3 September 2017

Raffaele Orlando

13

1 reference

3 September 2017

Fabrizio Scordino

14

1 reference

3 September 2017

Brent E Korba

15

1 reference

3 September 2017

language of work or name

1 reference

1 January 2007

1 reference

Journal of Gastroenterology and Hepatology

3 September 2017

published in

1 reference

3 September 2017

volume

22

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

86-91

1 reference

Approach to the patient with chronic hepatitis C virus infection

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Course and outcome of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Hepatocellular carcinoma and hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Assessment of iatrogenic transmission of HCV in Southern Italy: was the cause the Salk polio vaccination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Anti‐tumor Activity of Arginine Deiminase from Mycoplasma arginini and Its Growth‐inhibitory Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Efficient initiation of HCV RNA replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Distribution of nitric oxide synthase in normal and cirrhotic human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

Regression of fibrosis in chronic hepatitis C after therapy with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

The rising health and economic burden of chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04463.X

10.1111/J.1440-1746.2006.04463.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference